Futura Medical to present MED3000 FM71 data at the European Society for Sexual Medicine Congress 2023
Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology, with a current focus on sexual health and pain, today announces that it will be presenting data on its lead product MED3000 for the treatment of erectile dysfunction (“ED”) at the European Society for […]